Olga Granaturova is a co-founder of multiple biotech companies and a long-time pharmaceutical and biotechnology executive. With a diverse background spanning the entire value chain from R&D to commercial launch, Olga has navigated companies of all sizes and growth stages. Her expertise encompasses critical business functions such as company building, corporate strategy, business development, fundraising, licensing, partnering, and mergers and acquisitions. Olga's entrepreneurial spirit and dedication to advancing life-changing innovations earned her a well-deserved spot on Inc. Magazine's Female Founders 100 List in 2022, an honor reserved for women innovators whose work is making the world a better place. Beyond her entrepreneurial endeavors, Olga serves on the boards of Incendia Therapeutics and Coucou Nous Voilou, a nonprofit organization dedicated to pediatric oncology. She is also a co-founder of Brighter Ventures, a nonprofit organization championing women-led entrepreneurship and sponsoring women education in AI lifesciences. Olga's academic credentials include a BS in Pharmaceutical Sciences from SUNY at Buffalo School of Pharmacy and a TRIUM Global MBA from the NYU Stern School of Business, HEC Paris, and the London School of Economics and Political Sciences.